Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)

NCT04816604 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

74

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: GB002 (seralutinib)
DEVICE: Generic Dry Powder Inhaler

Sponsor

GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.